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Objectives: We analysed the architecture and probable origin of a class 1 integron from cefotaxime-
resistant Morganella morganii isolates.
Methods: bla genes and class 1 integron elements were detected by PCR and DNA–DNA hybridization
in a M. morganii strain isolated in 1996. PCR-mapping and sequencing of different fragments were
carried out to determine the integron’s architecture.
Results and conclusions: A class 1 integron (In116), strongly related to the In6/In7 family, was detected
in a plasmid from an oxyimino-cephalosporin-resistant M. morganii strain, producing CTX-M-2 b-lacta-
mase. The variable region of In116 contains aacA4, blaOXA-2 and orfD cassettes. Downstream of the 3
0-
conserved-segment (30-CS), an orf513-containing common region is followed by blaCTX-M-2 and flanking
regions, having 96–99% nucleotide identity with Kluyvera ascorbata’s kluA-1 and neighbouring
sequences. Some of the evidence supporting the incorporation of foreign DNA is as follows: a partial
deletion in a second 30-CS (30-CS2), and the absence of 59-base element or IS-like structures upstream of
blaCTX-M-2.
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Introduction
Plasmid-borne extended-spectrum b-lactamases (ESBLs) are
associated with different genetic elements like transposons and
integrons. Integrons are able to capture and mobilize different
gene cassettes, whose expression is controlled by a suitably
orientated promoter, by an integrase-mediated site-specific
recombination, usually occurring at the attI recombination site.1
Currently, nine integron classes are recognized, class 1 inte-
grons being the most frequently reported and distributed among
Gram-negative clinical isolates.2
The general organization of a class 1 integron includes: a
50-conserved-segment (50-CS), containing the divergently-tran-
scribed intI1 gene, most of attI1, and the promoter region;
the 30-conserved-segment (30-CS), including at least two genes,
qacED1 (basal-level resistance to quaternary-ammonium
compounds) and sul1 (sulphonamide resistance); and a variable
region (between both conserved domains) harbouring the gene
cassettes with the corresponding attC or 59-base element
(59-be).1
Unusual class 1 integrons, having a partial duplication of
30-CS, and a 2.1 kb region lying between both 30-CSs, called
the common region (CR), have been reported. Adjacent to CR
resides a unique region containing an antibiotic resistance gene,
not resembling a gene cassette. The first integrons of this family
were In6 and In7,3,4 harbouring catA2 (chloramphenicol resist-
ance) and dfrA10 (trimethoprim resistance), respectively.
A growing number of these integrons have been reported in
different regions and species,5,6 including In34 and InS21
(blaCTX-M-2) from Proteus mirabilis and Salmonella Infantis,
respectively, isolated in Argentina.7,8
We have previously detected the presence of a plasmid-
encoded CTX-M-2-type cefotaximase in six oxyimino-cephalos-
porin-resistant Morganella morganii isolates, collected during
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1996–1997, being the first report of a cefotaximase-mediated
resistance in the species.9 In this study, we establish
the association of this cefotaximase with a complex class 1 inte-
gron, named In116, in a cefotaxime-resistant M. morganii strain
isolated during 1996.
Materials and methods
Bacterial strains and DNA
Morganella morganii PP16, isolated from a urinary tract infection
during 1996 in Buenos Aires, was previously characterized as a
producer of a pI 8.2 cefotaximase (cefotaxime MIC 64 mg/L) and
TEM-1.9 Escherichia coli CAG12177 (E. coli Genetic Stock Center,
USA) and Escherichia coli Top10F0 (Invitrogen, USA) were used as
hosts for conjugation and transformation assays, respectively.
Control strains: E. coli 1353 (blaTEM-1, blaCTX-M-2) kindly provided
by M. Radice (Universidad de Buenos Aires); E. coli J53(RGK)
(blaTEM-1) and E. coli J53.2 86-1 (blaSHV-2) kindly provided by
A. Medeiros; Salmonella Infantis S21 (blaCTX-M-2, blaOXA-2, class 1
integron).8
Plasmid DNA from M. morganii PP16 (pM16), vectors and geno-
mic DNA were purified by conventional methods,10 or by commercial
systems (GFx Micro Plasmid Prep Kit; Amersham Biosciences, USA).
PCR screening
Screening for b-lactamase-encoding genes (bla) and class 1-integron
elements was carried out by PCR, using pM16 as template, 0.8–1
mM primers (Table 1), and 1.25 U of Taq DNA polymerase
(Amersham Biosciences, USA) or 1.5 U of Pfu polymerase
(Promega, USA), as required. PCR-amplicons were resolved in
1–1.3% agarose gels, using commercial standards (1 kb DNA
Ladder; MBI-Fermentas, Lithuania).
DNA–DNA hybridization
Overnight M. morganii colonies, transferred to nitrocellulose mem-
branes, and DNA dot-blots were treated as described previously.10
Gene probes were generated by PCR from control strains and
32P-labelled by random priming.10 Hybridization was carried out
overnight at 608C, and detected by radioautography, using Kodak
BioMax MS films and revealing solutions (Kodak, USA).
Conjugative transfer of pM16
The conjugative mobilization of pM16 was attempted by both
liquid- and solid-medium mating, to recipient E. coli CAG12177.10
Selection was carried out on Luria–Bertani or MacConkey agar
plates containing cefotaxime (10 mg/L) and tetracycline (20 mg/L).
Table 1. Oligonucleotides used for both PCR amplification and DNA sequencing
No. Primer Nucleotide sequence (50 ! 30) Target DNA Accession no.
1 I5 ACC GCC AAC TTT CAG CAC AT intI1 gene M95287
2 I3 GCG TTC GGT CAA GGT TCT GG intI1 gene M95287
3 5CS GGC ATC CAA GCA GCA AGC gene cassettes region M73189
4 3CS AAG CAG ACT TGA CCT GAT gene cassettes region M73189
5 qacED1F ATC GCA ATA GTT GGC GAA GT 30-CS (qacED1) X15370
6 qacED1B CAA GCT TTT GCC CAT GAA GC 30-CS (qacED1) X15370
7 Sul1F CTT CGA TGA GAG CCG GCG GC 30-CS (sul1) X12869
8 Sul1B GCA AGG CGG AAA CCC GCG CC 30-CS (sul1) X12869
9 Oxa2A CCT GCA TCG ACA TTC AAG ATA blaOXA-2 X03037
10 Oxa2B CTC AAC CCA TCC TAC CCA CCA blaOXA-2 X03037
11 Oxa2F ACT TCC TCC AGT CAG AAC blaOXA-2 this study
12 Oxa2-59 CTA CCC ACC AAC CCA TAC blaOXA-2 this study
13 IC1 AAT GCC TCG ACT TCG CTG aac(60)-Ib this study
14 AAC4 TCA CCA AGA TCC AAA CGG aac(60)-Ib this study
15 ORFD-59 ATT CTG CGG TCG GCT TAC orfD cassette this study
16 ORFend CCG TTA AGC TCT TAT GTG GG orf513 L06418
17 F12D GTA TTG CGC CGC TCT TAG AC sul1+orf513 this study
18 F12R AAA CCA GCA TGG TTG GCT AC sul1+orf513 this study
19 blaI TTA ATG ATG ACT CAG AGC ATT blaCTX-M-2 X92507
20 blaII GAT ACC TCG CTC CAT TTA TTG C blaCTX-M-2 X92507
21 blaIII CTG TTC GCC TGC GCA TGC AGC blaCTX-M-2 X92507
22 blaIV TAC CCA ACC GGA GCA GAA GG blaCTX-M-2 X92507
23 blaUp GGC TTC CAG CTG CTG TTG CAC blaCTX-M-2 this study
24 blaDn TTG ACT GTC GAC CCC AAA TCC blaCTX-M-2 this study
25 IV16D TGG ATA AGG AGG GGA CAA TG orf3 this study
26 blaTEM-1 ATG AGT ATT CAA CAT TTC CG blaTEM J01749
27 blaTEM-II CCA ATG CTT AAT CAG TGA GC blaTEM J01749
28 SHV-1A ATG ATG AGC ACC TTT AAA GTA blaSHV M59181
29 SHV-1B ATT TCG CTC GGC CAT GCT CGC blaSHV M59181
30 blaPER-I TGT GTT TTC ACC GCT TCT GCT CTG blaPER-2 X93314
31 blaPER-II CAG CTC AAA CTG ATA AGC CGC TTG blaPER-2 X93314
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Standard reactions were carried out for 2 h at the corresponding tem-
perature, and fragments resolved as above. Restriction endonucleases
used: EcoRV, EcoRI, Pst I, Eco47III, HindIII, HincII (New England
Biolabs, USA), SphI, NotI, PvuII, AvaI and SacI (Pharmacia, USA).
PCR mapping of In116 and DNA sequencing
PCR amplifications, using different pairs of primers (Table 1 and
Figure 1), were carried out to assess the architecture of the class 1
integron. PCR products were cloned into pGEM-T (Promega, USA)
or pUC18 (Amersham Pharmacia, USA) vectors, according to
manufacturers’ recommendations, and sequenced in both strands,
from recombinant plasmids, by the automated Sanger method.11
Sequences were analysed with the NCBI (http://www.ncbi.nlm.nih.
gov/) and EBI (http://www.ebi.ac.uk/) tools.
Nucleotide sequence accession number
The sequence of In116 has been submitted to the EMBL database
under the accession no. AJ621187.
Results and discussion
Plasmid detection and screening of bla genes
The presence of the following bla genes was detected in a 54 kb
plasmid (pM16) from M. morganii PP16: blaTEM (0.85 kb),
blaCTX-M-2-type (0.9 kb), and blaOXA (0.5 kb). Therefore, plas-
mid-borne b-lactamases would be responsible for the acquired
resistance to b-lactams in this strain, oxyimino-cephalosporin
resistance being mediated by the CTX-M-2-type enzyme.
No blaSHV or blaPER-2 could be detected, indicating that
M. morganii PP16 is not an SHV- or PER-producer.
Conjugative transfer of pM16
We failed to transfer pM16 plasmid to a recipient E. coli strain,
both by solid- and liquid-medium reactions. This was probably
due to a very low efficient conjugation, an incomplete mobiliz-
ation because of the size of pM16, or even a host species not
able to allow the conjugation. Though a Proteus mirabilis strain,
phylogenetically closer to M. morganii, could have been used,
the multiresistant Morganella strain made it extremely difficult
to find the proper conditions for selection of transconjugant
cells.
Sequencing and analysis of ESBL-encoding gene
and upstream region
The sequence of a 1.4 kb fragment containing blaCTX-M and its
upstream region showed a strict identity with the CTX-M-2-
encoding gene. The deduced protein has a single amino acid
shift (Arg-246! Ser) compared with Toho-1 (99% identity).
According to a theoretical 3D model of CTX-M-2 against
Toho-1 (not shown), this shift would not influence the catalytic
activity, and similar kinetic properties are expected. Moreover,
these two cefotaximases are presumably derived from
Figure 1. (a) Architecture of In116 (not to scale) deduced by a PCR mapping strategy. Genes are represented by bold arrows, indicating the direction of tran-
scription; circles represent 59-be. Numbers in italic correspond to sizes (in kb) of the PCR products. For simplification, only those PCR products cloned for
sequencing are shown. Primers are represented as arrows and numbers (Table 1). orf3 and qacED1 seem to exist as a gene fusion (orf3::qacED1), as proposed
elsewhere.7 (b) Detail of the squared region from (a): schematic comparison of common regions (CR) and 30-CS2 from In6/In7-related integrons. Top: the CR
(bold nucleotides) starts at +24 bp from the sul1 stop codon (underlined ‘TAG’). Bottom: 28 bp region containing the putative Orf513 recognition site (under-
lined 17 bp). Deletions in 30-CS2 are represented as squared numbers, except for In60 (no deletion). Note that only deletions in 30-CS2 50 end are indicated.
Complex class 1 integron in Morganella morganii
463
 by on M






chromosome-encoded b-lactamases from infrequent human
pathogens, such as Kluyvera species.12
A putative promoter was predicted upstream of blaCTX-M-2
in pM16, in good agreement with the experimental evidence
for a blaCTX-M-2 promoter in a Salmonella enterica strain
(J. Di Conza, unpublished results). This 506 bp upstream region
could be divided into a proximal 266 bp segment having 97%
identity with an equivalent region upstream of Kluyvera ascor-
bata kluA-1 (AJ272538), reinforcing the hypothesis of their phy-
logenic relationship, and a distal 240 bp segment, showing strict
identity with the CR, reported in In6/In7 integrons,4 including
InS21 and In35, among others.7,8 The last 17 bp of this 240 bp
region were postulated as a putative recombination site for inser-
tion of resistance genes.13 It is worth noting the absence of
ISEcp1 in M. morganii PP16, associated with blaCTX-M-9 and
blaCTX-M-1 sub-families,
14,15 including a chromosome-encoded
blaCTX-M-3 from a K. ascorbata strain.
16
These features suggest the acquisition of blaCTX-M-2 via ‘non-
IS-mediated’ mechanisms, although the presence of a hypotheti-
cal recombination site could indicate an earlier transposition,
followed by the loss of the IS, probably by recombination events.
Detection and analysis of class 1 integron elements
Typical elements of class 1 integrons were detected by PCR and
sequenced: intI1 from 50-CS, sul1 and qacED1 from 30-CS, and
a 2 kb variable region (Figure 1a), including the following gene
cassettes: aacA4-cassette, encoding an aminoglycoside acetyl-
transferase, which probably mediates the aminoglycoside resist-
ance in this strain;9 blaOXA-2-cassette, encoding an OXA-2
b-lactamase; and an open reading frame (orfD) of unknown
function. Notably, this gene-cassette arrangement was also
observed in four other M. morganii strains (data not shown), in
InS21 and In35,7,8 and in a Klebsiella pneumoniae isolate from
Uruguay (R. Vignoli, Universidad de la Repu´blica, Montevideo,
personal communication), suggesting a common origin of these
integrons.
Description of In116 architecture
The map of In116, obtained by a PCR-based strategy and
sequencing, is showed in Figure 1(a). In116 has 99.7% identity
with InS21, and a similar structure to the In6/In7 family, rein-
forcing the idea of their common origin and probably a recent
dissemination. Twenty nucleotide differences were detected in
In116, compared with InS21, including the ‘TGAACT’ 10
consensus sequence in the PANT promoter (‘TAAACT’ in
InS21).
A 2.1 kb segment having 99% identity with the CR from
In6/In7-type integrons was present downstream of 30-CS.3,4,7,8
This extension includes an orf513, followed by a 28 bp con-
served sequence containing a putative 17 bp signal for the
hypothetical recombinase Orf513, which probably leads to the
incorporation of resistance genes (Figure 1b). A resistance gene,
depending on the integron, is located downstream of the 28 bp
region: blaCTX-M-2 (In116), catA2 (In6),
4 dfrA10 (In7),3 blaDHA-1
(pSAL-1 integron),5 blaCTX-M-9 (In60),
6 etc. (Figure 1b).
Notably, associated resistance genes and flanking sequences
from In116 and the pSAL-1 integron have high homology with
chromosomal DNA from other species: K. ascorbata and
M. morganii, respectively. A 96–99% identity between blaCTX-M-2
and flanking sequences with a homologous sequence including
K. ascorbata kluA-1 suggests their incorporation was probably
Orf513-mediated and used a 28 bp target sequence. This feature
endorses the hypothesis of the chromosomal origin of
plasmid-borne b-lactamases, probably mobilized from different
microorganisms to more promiscuous structures (integrons,
transposons or plasmids).
As in In6/In7, In116 showed a partial duplication of 30-CS
(30-CS2), lacking the first 70 bp. A 30 28 bp deletion also
occurred in orf3, probably allowing the continuity of orf3 and
qacED1 from 30-CS2, thus encoding a putative fusion protein,
Orf3::QacED1. These deletions (variable depending on the inte-
gron, Figure 1b) might have participated in recombination events
implicated in the acquisition of foreign associated resistance
genes, probably replacing less useful regions of DNA.
In summary, pieces of evidence supporting the hypothesis
of the incorporation of blaCTX-M-2 and flanking sequences from
K. ascorbata in In116 are: (i) the absence of attC-like structures,
and the presence of a putative recombinase-encoding gene
(orf513) suggesting the acquisition of the resistance gene by a
non-site-specific recombination mechanism; (ii) a partial deletion
in 30-CS2, probably associated with the incorporation of foreign
DNA (see above); and (iii) the absence of IS-like structures
(ISEcp1 or related) upstream of blaCTX-M-2, suggesting a different
mechanism, or even an earlier transposon-mediated incorporation
followed by a loss of any ‘trace’ from that event. If the latter had
happened, In116 and related integrons could be more recent than
the IS-associated ones.
So far, only blaCTX-M and blaDHA-1 genes have directly been
associated with chromosome-borne genes. We could hypothesize
that perhaps other In6/In7-associated resistance genes have been
derived from a variety of chromosomal sources, probably using
a similar mechanism: an initial collection from parental microor-
ganisms by a still unknown strategy (probably transposon- or
phage-mediated), followed by the acquisition of the whole
fragment in the integron environment, presumably using a
recombinase (Orf513) activity and not fully determined target
sequences.
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